Investments and investor services
Proactive news highlights: IOG, Motif Bio, allergy Therapeutics, ReNeuron, Immupharma and more
Sunrise Resources, Optibiotix Health and ITM Power also had news out
Company
OptiBiotix Health PLC
LON:OPTI
OptiBiotix Health Plc is a life sciences company operating in one of the most progressive areas of biotechnological research. Developing and commercialising technologies that modulate the human microbiome – the collective genome of the microbes in the body – the company identifies and develops prebiotic formulations and compounds for use in food ingredients and supplements that can impact on human physiology and metabolism, deriving potential health benefits.
574 stories · page 27 of 29
Markets: InternetQ hits back at online blog post
The FTSE100 was around 30 points higher at 6,267 with aerospace engine maker Rolls Royce leading the way.
Investments and investor services
Markets rise despite downbeat UK manufacturing news
The Footsie rose 30.9 points to 6269.19 while mainland European markets also gained
Optibiotix brings in £1.5mln to develop business further
Life sciences firm OptiBiotix Health has raised £1.5mln in a placing to develop its growing business further....
Investments and investor services
Proactive news highlights: AFC Energy, Stellar Diamonds, Eckoh, PureCircle and Clinigen
Anglo Asian Mining, Kefi Minerals and Andes Energia also has news out today
OptiBiotix to extend platform with new development deal
Life sciences firm OptiBiotix Health has struck a development deal with Italian group Centro Sperimentale Del Latte (CSL)....
Small cap highlights: A Plethora of winners
Three life sciences firms with products aimed at the consumer end of the market were to the fore this week
Investments and investor services
Proactive small cap highlights – SolGold, Diamondcorp, Aureus, Globo, ITM Power, Providence Resources, Lansdowne, and more
Here are the Proactive Investors small cap news highlights for Tuesday November 3.
OptiBiotix Health adds extra levels of protection to its IP
OptiBiotix Health has filed two new patents relating to its cholesterol-reducing product.
Optibiotix's potential highlighted by new report, says chief
OptiBiotix (LON:OPTI) chief Stephen OHara today highlighted a new report, which says the human microbiome market is expected to reach a whopping US$658 million by 2023
Investments and investor services
FTSE100 finishes the week on the front foot
China and the ECB left investors in a positive mood at the end of the week
Investments and investor services
Proactive news highlights: Venn Life Sciences, Optibiotix, Petropavlovsk, Mart, 88 Energy and more
Pharma companies and energy firms were in the news today...
FTSE 100 advance accelerates as China cuts rates
China has cheered the market, especially investors in resource stocks, by announcing further stimulus measures
Investments and investor services
Risers & Fallers: AA, Travis Perkins, Shire, ServicePower and Pearson...
Below are the main news-driven share price movements at 4pm.
Investments and investor services
Eurozone stimulus hints boost blue-chip shares
Footsie broke above 6400 and mainland European bourses also rose
OptiBiotix rises as sugar tax is mooted
OptiBiotix is developing a range of non-digestible natural healthy sugars with zero calories that could help tackle an epidemic estimated to be costing the NHS £5.1bn annually.
Archive
Proactive news summary, including Renewable Energy Generation, Premier African Minerals, Botswana Diamonds and Abzena
A mixed news bag to end the week. Here is a summary....
OptiBiotix Health building strong IP asset base, says broker
"Strong intellectual product and scientific advances will strengthen OptiBiotix’s position at the bargaining table," Hybridan said.